MaxCyte Investor Presentation Deck

MaxCyte Business Model - Cell Therapy Market CELL THERAPY - Cell itself is the Drug Key Applications: Ex-Vivo Engineered Cell Therapies Customer Base: Leading global cell therapy developers and academic translational centers Preclinical and Academic Revenue Model SPL Partnership Model Instrument Sale (ATX/GTX) Primarily ATX given early development AT RUO ¹0 Small/mid-scale Annual Instrument License Fee (GTX) (Research / Clinical) Full scale GTX CGMP + 11 + Single-use Disposables (processing assemblies) Full scale GTX RUO Single-use Disposables (processing assemblies) + Strategic Partnership Terms M MaxCyte Razor/Razor Blade Economics Razor/Razor Blade Economics and Share of Therapeutic Economics © 2023 MaxCyte, Inc. All Rights Reserved

View entire presentation